TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 12.20
+0.10 (0.83%)
Feb 11, 2026, 1:30 PM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 8.61 billion as of February 11, 2026. Its market cap has increased by 12.14% in one year.
Market Cap
8.61B
Enterprise Value
7.83B
Revenue
38.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.20
Market Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 8.61B, a decrease of -79.53%. That is a compound annual growth rate of -11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 8.61B | -9.70% |
| Dec 31, 2025 | 9.54B | 16.05% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 13.07B |
| Medigen Vaccine Biologics | 11.98B |
| TCM Biotech International | 10.81B |
| Gongwin Biopharm Holdings | 9.00B |
| PharmaEngine | 8.98B |
| Acepodia | 8.09B |
| Adimmune | 7.65B |
| Mycenax Biotech | 6.91B |